Enviar artigo por via de e-mail Contrast Agents Based on Iron Oxide Nanoparticles for Clinical Magnetic Resonance Imaging
- Autores: Abakumov M.1,2, Ternovoi S.3,4, Mazhuga A.2,5,6, Chekhonin V.1, Demikhov E.7, Pistrak A.7, Konstantinov M.7, Dmitriev D.7, Myshkinis B.8
-
Afiliações:
- N. I. Pirogov Russian Research Medical University, Ministry of Health of the Russian Federation
- Biomedical Nanomaterials Laboratory, National University of Science and Technology MISIS
- National Medical Research Center for Cardiology, Ministry of Health of the Russian Federation
- I. M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of the Russian Federation
- Faculty of Chemistry, M. V. Lomonosov Moscow State University
- D. I. Mendeleev Russian Chemical Technological University
- P. N. Lebedev Physical Institute, Russian Academy of Sciences
- Gelpik Company
- Edição: Volume 167, Nº 2 (2019)
- Páginas: 272-274
- Seção: Biotechnologies
- URL: https://journals.rcsi.science/0007-4888/article/view/241637
- DOI: https://doi.org/10.1007/s10517-019-04507-y
- ID: 241637
Citar
Acesso aberto
Acesso está concedido
Somente assinantes
Resumo
Magnetic resonance imaging (MRI) is one of the most perspective methods of noninvasive visualization in medicine, and use of contrast agents significantly its potentialities extends. Iron oxide nanoparticles are promising contrast agents, but in fact all the data on their efficiency were obtained in high-field tomographs for experimental animals. We studied the possibility of using magnetic nanoparticles for MRI visualization of rat brain glioblastoma at the most common clinical field 1.5 T The data indicate the efficiency of iron oxide magnetic nanoparticles as contrast agents for 1.5 T MR tomographs.
Sobre autores
M. Abakumov
N. I. Pirogov Russian Research Medical University, Ministry of Health of the Russian Federation; Biomedical Nanomaterials Laboratory, National University of Science and Technology MISIS
Autor responsável pela correspondência
Email: abakumov1988@gmail.com
Rússia, Moscow; Moscow
S. Ternovoi
National Medical Research Center for Cardiology, Ministry of Health of the Russian Federation; I. M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of the Russian Federation
Email: abakumov1988@gmail.com
Rússia, Moscow; Moscow
A. Mazhuga
Biomedical Nanomaterials Laboratory, National University of Science and Technology MISIS; Faculty of Chemistry, M. V. Lomonosov Moscow State University; D. I. Mendeleev Russian Chemical Technological University
Email: abakumov1988@gmail.com
Rússia, Moscow; Moscow; Moscow
V. Chekhonin
N. I. Pirogov Russian Research Medical University, Ministry of Health of the Russian Federation
Email: abakumov1988@gmail.com
Rússia, Moscow
E. Demikhov
P. N. Lebedev Physical Institute, Russian Academy of Sciences
Email: abakumov1988@gmail.com
Rússia, Moskva
A. Pistrak
P. N. Lebedev Physical Institute, Russian Academy of Sciences
Email: abakumov1988@gmail.com
Rússia, Moskva
M. Konstantinov
P. N. Lebedev Physical Institute, Russian Academy of Sciences
Email: abakumov1988@gmail.com
Rússia, Moskva
D. Dmitriev
P. N. Lebedev Physical Institute, Russian Academy of Sciences
Email: abakumov1988@gmail.com
Rússia, Moskva
B. Myshkinis
Gelpik Company
Email: abakumov1988@gmail.com
Rússia, Moscow
